Authors: OREILLY S ROWINSKY E SLICHENMYER W DONEHOWER RC FORASTIERE A ETTINGER D CHEN TL SARTORIUS S BOWLING K SMITH J BRUBAKER A LUBEJKO B IGNACIO V GROCHOW LB

Citation: S. Oreilly et al., PHASE-I AND PHARMACOLOGICAL STUDIES OF TOPOTECAN IN PATIENTS WITH IMPAIRED HEPATIC-FUNCTION, Journal of the National Cancer Institute, 88(12), 1996, pp. 817-824